SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-004847
Filing Date
2021-02-03
Accepted
2021-02-03 21:07:54
Documents
2
Period of Report
2021-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4671
2 EX-24 DOCUMENT attachment1.htm EX-24 3794
  Complete submission text file 0000899243-21-004847.txt   9855
Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
Mulligan Richard (Reporting) CIK: 0001376247 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39941 | Film No.: 21588461

Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)